PuraCap Wuhan, founded in 2009, is located in the Wuhan Biological Industry Base. Covering 60,000 square meters, the plant has advanced facilities introduced from South Korea, United States and Europe, and is focused on the production of generic drugs, prescription drugs and over-the-counter products. It is the first pharmaceutical plant in Hubei province approved by the FDA, and it is the one of the few Chinese pharmaceutical companies that has passed the FDA cGMP site audit without defect. Today the Wuhan plant is a supplier of American major medicine retailers.
